FDA — authorised 18 September 2001
- Application: ANDA075298
- Marketing authorisation holder: WAYLIS THERAP
- Status: supplemented
FDA authorised Eulexin on 18 September 2001
Yes. FDA authorised it on 18 September 2001; FDA has authorised it.
WAYLIS THERAP holds the US marketing authorisation.